Therapie

Papers
(The TQCC of Therapie is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers86
Uses of pharmacovigilance databases: An overview81
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection68
Safety data and withdrawal of hepatotoxic drugs52
Addictovigilance contribution during COVID-19 epidemic and lockdown in France48
Pharmacovigilance and drug safety: Fair prescribing and clinical research47
Drug repositioning for rare diseases: Knowledge-based success stories40
Polypharmacy: A general review of definitions, descriptions and determinants37
Drug repurposing in rare diseases: Myths and reality33
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence33
Efficacy of COVID-19 vaccines: From clinical trials to real life28
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)26
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres24
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge23
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations21
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy21
Diabetes and COVID-1921
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France20
Chloroquine and hydroxychloroquine during pregnancy: What do we know?19
Orphan drug clinical development17
Self-medication practices and their characteristics among French university students16
Prolonged-release buprenorphine formulations: Perspectives for clinical practice16
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-1915
Genital tract and reproductive characteristics in daughters of women and men prenatally exposed to diethylstilbestrol (DES)13
COVID-19 and NSAIDs: Primum non nocere12
COVID-19 vaccines: A perspective from social pharmacology12
Update on bradykinin-mediated angioedema in 202012
Thrombotic events after AstraZeneca vaccine: What if it was related to dysfunctional immune response?11
Innovative approaches in CNS drug discovery11
Warning on increased serious health complications related to non-medical use of nitrous oxide9
Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature9
Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials9
Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment9
Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database9
Orphan drug designation in Europe: A booster for the research and development of drugs in rare diseases9
Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials9
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review9
Epidemiology and economic burden of “serious” adverse drug reactions: Real-world evidence research based on pharmacovigilance data9
Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 20218
La pharmacogénétique au service du soin en France : une discipline qui évolue !8
Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France8
Incretin-based drugs and intestinal obstruction: A pharmacovigilance study8
Is the drug a scientific, social or political object?8
NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection8
Consommation de substances chez les jeunes : du médicament aux substances illicites7
Drugs acting on renin angiotensin system and use in ill patients with COVID-197
A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy7
Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance Centres7
Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions7
Penetration rate of anti-TNF biosimilars and savings at 5 years after their introduction in French hospitals6
Drug-induced meningitis: A review of the literature and comparison with an historical cohort of viral meningitis cases6
Vaccines and Bell's palsy: A narrative review6
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data6
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-196
Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol6
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-196
Atteintes musculaires et levure de riz rouge : analyse des données de la base nationale de pharmacovigilance et revue de la littérature6
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic6
The challenges of pharmacoepidemiology of orphan drugs in rare diseases6
Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database6
COVID-19 vaccines and pregnancy: What do we know?6
Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic5
Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data5
Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine5
Connaissances et attitudes des médecins généralistes à l’égard des effets indésirables des inhibiteurs de la pompe à protons5
Are β-lactam concentrations adequate in severe sepsis and septic shock in children?5
Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-195
The French pharmacovigilance surveys: A French distinctiveness, a real input5
Le mésusage du fentanyl en France : 2010 à 20155
Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis5
Les politiques de partage de données des financeurs d’essais cliniques en France5
Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance5
Analyse des seringues usagées : un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse ?5
Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen4
Patients’ organizations in rare diseases and involvement in drug information: Illustrations with LMC France, the French Association of Chronic Myeloid leukemia4
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series4
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study4
Drug consumption during prolonged lockdown due to Covid-19 as observed in French addiction center4
Global research output in ‘pharmacovigilance’ during 2010–20204
Les médicaments potentiellement inappropriés : adaptation de la liste EU(7)PIM à la pratique médicale française4
Is caspofungin efficient to treat invasive candidiasis requiring continuous veno-venous hemofiltration? A case report4
Statin-associated myasthenia: A case report and literature review4
Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy4
An old drug for a rare disease: The example of celiprolol for vascular Ehlers-Danlos syndrome4
The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions4
The drugs that mostly frequently induce gynecomastia: A national case – noncase study4
Quality of evidence of the efficacy of therapeutic interventions on patient-important outcomes in Cochrane's systematic reviews’ abstracts: A survey4
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects3
Déclaration des erreurs médicamenteuses dans les recherches portant sur le médicament : place du pharmacien des essais cliniques ?3
Use of triptans during pregnancy? With caution!3
DPP-4 inhibitors and severe course of illness in patients with COVID-193
Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN)3
Meningiomas after cyproterone acetate exposure: Case reports in twin sisters3
Pharmacologie du cannabidiol : points de vigilance, conséquences et risques chez l’homme3
Towards personalized pharmacology: Antipsychotics and schizophrenia3
Green tea and hepatoxicity: Two case reports3
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients3
Sex differences: From preclinical pharmacology to clinical pharmacology3
Severe bone pain with teriflunomide: Five case reports and review of the French pharmacovigilance database3
Évaluation du potentiel d’abus et de dépendance de la quétiapine (Xeroquel®)3
A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)3
Immunotherapies in acute leukemia3
Interactions médicamenteuses avec la colchicine, les contre-indications sont-elles bien respectées ? Étude descriptive des prescriptions en Bretagne à partir des données de l’Assurance maladie3
Trente ans d’abus de néfopam en France3
Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process3
DRESS syndrome with cholecystitis in a child: A case report and literature review3
Androgens, QT, sex and ventricular repolarization–a double-edged sword: A case series3
Bacterial infections in people who inject psychoactive substances: An observational study in a French university hospital3
Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports3
Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus3
Raising public awareness about the misuse of predatory journals: One year after the “hydroxychloroquine and push-scooters accidents” hoax3
Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives3
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study3
Pharmaciens d’officine, étudiants en pharmacie et demandes de médicaments à base de codéine : étude observationnelle3
Cinderella side effect: Intravenous corticosteroid-induced bradycardia3
Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice3
Urticaire sévère avec récidive compliquée d’angiœdème sous sécukinumab : à propos d’un cas3
Minors and young adult's hospitalizations after “chimique” consumption in Mayotte Island: Which substances are involved?3
Platform trials3
The “old” cytotoxic drugs, the basis of anti-cancer treatments3
Syndrome coronarien aigu associé au dronabinol2
Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted2
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 20222
Consommer du CBD ou conduire, faut-il choisir ?2
A case of iatrogenic vitamin D toxicity revealed by drug reconciliation2
Olmesartan-associated enteropathy: Belgian survey2
Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology2
Contributions of animal models of cognitive disorders to neuropsychopharmacology2
Suivi thérapeutique pharmacologique de l’olanzapine2
No arguments for extra risk from ibuprofen in SARS-COV2 infection2
Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic2
Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-22
Usages de substances de synthèse en France et en Europe2
Étude observationnelle des déclarations de liens d’intérêts au Congrès de la médecine générale France et liens d’intérêts des médecins intervenants2
Severe serotonin syndrome caused by an interaction between an antidepressant and a cough syrup2
Imagerie TEP pour l’étude des répercussions fonctionnelles de la P-glycoprotéine en neuropharmacocinétique2
Pourquoi et comment améliorer l’information des patients et de leurs aidants au bon usage de leurs dispositifs médicaux tout au long du parcours de soin ?2
Les essais plateformes2
Efficacy and safety of neural stem cell therapy for spinal cord injury: A systematic literature review2
Suivi thérapeutique pharmacologique de la clozapine2
Health crisis: What opportunities for clinical drug research?2
Spiderweb-like pattern: A novel dermoscopic feature in photo-onycholysis induced by doxycycline?2
Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie2
Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review2
Hospitalisations après consommation de substances psychoactives pendant la pandémie de COVID-192
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections2
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic2
The discovery of hypoglycaemic sulphonamides – Montpellier, 19422
Ambulatory drug changes in the elderly after hospital discharge: A cohort study2
A methodological framework for drug development in rare diseases. The CRESim program: Epilogue and perspectives2
Hypoglycémie sévère et arrêt cardiorespiratoire attribués au tramadol – à propos d’un cas2
Letrozole induced visual hallucination2
Hypophosphatémie et fer injectable : à propos d’un cas et revue de la littérature2
Utilisation et gestion des inhibiteurs de la pompe à protons : une étude observationnelle2
Bismuth encephalopathy and mineral waters: a new hypothesis on bismuth absorption2
Pulmonary hemorrhage in a neonate born to a woman with cystic fibrosis treated with targeted cystic fibrosis transmembrane conductance regulator modulator elexacaftor–tezacaftor–ivacaftor during pregn2
Balneotherapy in spondyloarthropathy: A systematic review2
Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database2
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic2
Refractory non-variceal upper gastrointestinal bleeding in a liver-transplant patient: Everolimus withdrawal should be considered2
Poids atropinique et médicaments anticholinergiques : intérêt et application en pratique clinique chez la personne âgée2
Référentiel ECRIN pour la conformité aux bonnes pratiques de gestion des données des essais cliniques multinationaux2
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France2
Chronic spontaneous urticaria following vaccination against SARS-CoV-22
Prescription errors by emergency physicians for inpatients are associated with emergency department length of stay2
Buprénorphine d’action prolongée : quelles perspectives pour la pratique clinique ?2
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France2
The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?2
An atypical Ramsey Hunt syndrome after covid 19 immunization2
Adverse drug reaction monitoring: Doing it the French way – Act II2
Myocardial infarction in relation to colchicine poisoning: A precipitating cause of refractory toxic cardiogenic shock2
Les solutions numériques en santé, quelles valeurs apportées, quels mécanismes de financement et quelles évaluations ?2
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective2
Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss – An observational study using the EFEMERIS database2
Leukocytoclastic vasculitis mimicking photosensitivity induced by thiamazole2
Non-medical use of baclofen: A case series and review of the literature2
Pharmacokinetics of ceftolozane/tazobactam continuous infusion on renal replacement therapy: A pediatric case report2
Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey2
Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy2
Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma2
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®2
Évolution des comportements de consommation de produits psychoactifs illicites ou détournés de leur usage médicamenteux chez les femmes enceintes en France : analyse des données OPPIDUM de 2005 à 20182
0.033882141113281